Public Company News
EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
CHANGZHOU, China, Dec. 31, 2024 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a leading short-distance transportation solutions provider inChina, today announced that the Company had received a notification letter (the "Notification Letter") dated December 30, ...
2025-01-01 05:30
5211
Boqii Announces Fiscal 2025 First Half Unaudited Financial Results
SHANGHAI, Dec. 31, 2024 /PRNewswire/ -- Boqii Holding Limited ("We," "Boqii" or the "Company") (NYSE American: BQ), a leading pet-focused platform inChina, today announced its unaudited financial results for the first half of fiscal 2025 (i.e., the six months ended September 30, 2024). Fiscal 20...
2025-01-01 05:30
3371
Mingzhu Announces Unaudited Financial Results for the Six Months Ended June 30, 2024
SHENZHEN, China, Dec. 31, 2024 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ), an elite provider of logistics and transportation services to businesses, today announced its unaudited financial results for the six months endedJune 30, 2024. Mr. Jinl...
2025-01-01 05:00
5634
MicroAlgo Inc. Announces the Launch of FULL Adder Operation Quantum Algorithm Technology Based on CPU Registers in Quantum Gate Computing
SHENZHEN, China, Dec. 31, 2024 /PRNewswire/ -- MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the successful development of a groundbreaking quantum algorithm technology, specifically a FULL adder operation based on CPU registers in quantum gate computers. This inno...
2024-12-31 22:15
3575
CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy
SHANGHAI, Dec. 31, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the initiation of an investigator-initiated trial (IIT) inChina for K...
2024-12-31 21:50
3620
CG MedTech and CGBIO Showcase Korea's Spine Surgery Excellence to Global Experts
SEOUL, South Korea, Dec. 31, 2024 /PRNewswire/ -- CG MedTech (f/k/a Innosys, CEO Ju Mi Chung), a leading Korean orthopedic implant research and manufacturing company, partnered withCGBIO to host the International Spine Endoscopy Training Course. The event welcomed 12 medical professionals from nin...
2024-12-31 20:00
2889
New Oriental to Report Second Quarter 2025 Financial Results on January 21, 2025
BEIJING, Dec. 31, 2024 /PRNewswire/ -- New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services inChina, today announced that it will report its financial results for the second quarter endedNovember 30, ...
2024-12-31 17:00
2628
Ping An Health Supported the Official Release of the "Group Standards for Remote and Internet-Based Family Doctor Healthcare Services"
HONG KONG and SHANGHAI, Dec. 31, 2024 /PRNewswire/ -- With Ping An Healthcare and Technology Company Limited's ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) strategic support, and guidance from the General Practice Development Research Center of Peking Universit...
2024-12-31 15:26
4936
OneConstruction Group Limited Announces Pricing of Initial Public Offering
NEW YORK, Dec. 31, 2024 /PRNewswire/ -- OneConstruction Group Limited (" OneConstruction Group" or the "Company"), a structural steelwork contractor in Hong Kong, today announced the pricing of its initial public offering of 1,750,000 ordinary shares at a public offering price ofUS$4.00 per share ...
2024-12-31 13:37
6323
Ambow Education Announces Second Quarter and First Half of 2024 Financial Results
CUPERTINO, Calif., Dec. 30, 2024 /PRNewswire/ -- Ambow Education Holding Ltd. ("Ambow" or the "Company") (NYSE American: AMBO), a leading AI-driven educational and collaboration technology company, today announced its unaudited financial and operating results for the three-month and six-month per...
2024-12-31 05:01
5103
Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SEONGNAM, South Korea and BOSTON, Dec. 30, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis and cancer, today announced that James Jungkue Lee, Founder and CEO of Bridge Biotherapeutics, will present ...
2024-12-30 23:00
3052
Amcor completes previously announced sale of BCNA joint venture interest for $122 million; Proceeds used to reduce debt
ZURICH, Dec. 30, 2024 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, announced today it completed the sale of its 50% interest in Bericap North America (BCNA) for$122 million on December 27, with the proceeds used to redu...
2024-12-30 22:58
2827
MicroCloud Hologram Inc. Develops Semiconductor Quantum Dot Hole Spin Qubit Technology, Advancing the Frontiers of Quantum Computing
SHENZHEN, China, Dec. 30, 2024 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (the "Company"), based on their in-depth research and continuous innovation in quantum technology, they have pioneered an advanced technological solution: using a fast adiabatic driving protocol to achieve co...
2024-12-30 22:00
3276
CBAK Energy Announces Expansion in Nanjing: Equipment Procurement Completed and Trial Production Set for May 2025, Adding 3GWh of Capacity
DALIAN, China, Dec. 30, 2024 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy" or the "Company"), a leading manufacturer of lithium-ion and sodium-ion batteries and electric energy solutions inChina, today announced that its wholly-owned subsidiary, Nanjing CBAK New Energ...
2024-12-30 22:00
5325
CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T (Satri-cel)
SHANGHAI, Dec. 30, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the positive results from the pivotal Phase II clinical trial CT041-...
2024-12-30 21:50
2967
Hesai Achieves Milestone as the World's First Lidar Company to Deliver 100K Units Per Month
PALO ALTO, Calif., Dec. 30, 2024 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), the global leader in automotive lidar technology, today announced that the company has delivered more than 100,000 lidar units during the month of December, becoming the world's first lidar company to reach this mil...
2024-12-30 21:00
2862
Lichen China Limited Announces $3.1 Million Registered Direct Offering
XIAMEN, China, Dec. 30, 2024 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an a...
2024-12-30 20:30
4541
WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year
SHANGHAI, Dec. 30, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that it has been recognized by the prestigious Dow Jones Sustainability Indices ...
2024-12-30 20:00
3246
Emeren Group Signs 7-Year PPA for 15 MWp Solar Farm in Poland
NORWALK, Conn., Dec. 30, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the
"Company") (www.emeren.com
2024-12-30 19:00
2461
Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration
* Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a groundbreaking hybrid mesotherapy filler designed ...
2024-12-30 13:00
3331
Week's Top Stories
Most Reposted
AI adoption is widespread, but developer confidence is still catching up, Agoda report finds
[Picked up by 315 media titles]
2026-02-03 11:00
Mastercard Launches Portfolio of Fleet Solutions in Asia Pacific
[Picked up by 311 media titles]
2026-02-04 09:00Colebrook Bosson Saunders Officially Launches Lana, A Circular Ergonomic Laptop Stand for the Hybrid Generation
[Picked up by 305 media titles]
2026-02-03 12:00
Rockwell Automation Strengthens Industrial Cybersecurity with New Security Operations Center in Singapore
[Picked up by 298 media titles]
2026-02-09 10:00
AIA RESEARCH REVEALS INGRAINED HEALTH STEREOTYPES ARE HOLDING BACK WELLBEING IN ASIA
[Picked up by 287 media titles]
2026-02-09 16:08
